The New Standard in Blood Culture Contamination Reduction
Steripath® Gen2 (ISDD®) is supported by independent published clinical study results of 12-month sustained rates as low as 0.2% in the ED.2 With improved test results, patients can benefit from reduced risk of sepsis misdiagnosis and unnecessary antibiotic treatment.
How it Works
Divert harmful contaminants with one simple squeeze.
Steripath mechanically diverts and sequesters the initial 1.5-2.0 mL of blood, the volume known to most likely contain contaminants.1 Blood cultures are then collected through an independent sterile flow path maintaining a closed vein-to-bottle system.
Features & Technology
Evidence-Based Diversion Volume
According to independent clinical studies, 1.5-2.0mL is the recommended volume of blood to divert to reduce blood culture contamination.¹
Supports IV Start Draws
The 9”, CT compatible Luer extension remains with the patient after blood culture collection. Disconnection at the IV hub is not required.
User-Controlled Diversion
Gentle negative pressure assists in drawing the diverted blood, critical for ‘hard stick’ patients.
Independent, Sterile Flow Path
A second independent flow path automatically opens for specimen collection upon completion of diversion.
No Assembly Required
Comes pre-assembled and sterile to significantly reduce touch point contamination, providing a closed vein-to-bottle system.
Available in a Customizable Kit
Customized best practice kits for consistent, sustainable, guaranteed result.
Guaranteed clinical results,
or your money back.
50% Reduction Guarantee
We back Steripath with a clinical performance guarantee of a 50% or greater sustained reduction in blood culture contamination or your money back.
0.5% Rate Rebate
When used with the Best Practice Blood Culture Kit, and the 50% reduction has been surpassed, Magnolia Medical provides a $1,000 credit for any contamination above a 0.5% rate.
*additional terms and conditions may apply
Steripath® Blood Culture Collection System
Offering Universal Compatibility
Bottle Compatibility:
Available Extensions
Make an impact at your hospital by reducing blood culture contamination
Continue Reading
The Problem
Learn about the consequences of false-positive blood cultures
The Challenge
What differentiates Steripath Gen2 from other techniques and methods
The Benefits
The clinical & economic impact of reducing blood culture contamination
The Evidence
Explore the independent clinical study results using Steripath
References
1) Richard G. Patton Blood Culture Contamination Definitions Can Obscure the Extent of Blood Culture Contamination: A New Standard for Satisfactory Institution Performance Is Needed. Infection Control & Hospital Epidemiology, Available on CJO 2016 doi:10.1017/ice.2016.30
2) M. Rupp, et al:Reduction in Blood Culture Contamination Through Use of Initial Specimen Diversion Device. Clinical Infectious Diseases (August 2017)